SCHEMBL2123770

SCHEMBL2123770

Cc1ccc(S(=O)(=O)n2ccc3c(CCC(=O)O)cnc(C#N)c32)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PPARG P37231 2/20 0.38
▸ PPARD Q03181 2/20 0.38
▸ PPARA Q07869 1/20 0.38
▸ VEGFA P15692 1/20 0.38
▸ EGLN1 Q9GZT9 1/20 0.38
▸ BRD4 O60885 2/20 0.38
▸ MAPT P10636 2/20 0.36
▸ PSEN1 P49768 1/20 0.36
▸ PSEN2 P49810 1/20 0.36
▸ APH1B Q8WW43 1/20 0.36
▸ NCSTN Q92542 1/20 0.36
▸ APH1A Q96BI3 1/20 0.36
▸ PSENEN Q9NZ42 1/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ ALOX5 P09917 2/20 0.35
▸ PTGS2 P35354 1/20 0.35
▸ ALDH1A1 P00352 2/20 0.35
▸ KEAP1 Q14145 2/20 0.35
▸ NFE2L2 Q16236 2/20 0.35
▸ PTGDR2 Q9Y5Y4 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2122196 0.89 PIK3C3 (0.37) MAPTL3MBTL1ALDH1A1KDM4E
SCHEMBL10112242 0.88 MAPT (0.39) BRD4MAPTL3MBTL1ALDH1A1HTR6
SCHEMBL16336240 0.79 MAPT (0.41) BRD4MAPTL3MBTL1PTGS2ALDH1A1
SCHEMBL2121103 0.73 PIK3C3 (0.38) BRD4MAPTL3MBTL1ALDH1A1KDM4E
SCHEMBL13003407 0.72 PPARG (0.43) PPARGPPARDPPARAVEGFAEGLN1
SCHEMBL2125502 0.72 ALOX5 (0.39) PPARGPPARDPPARAVEGFAEGLN1
SCHEMBL2121064 0.72 ALDH1A1 (0.38) MAPTL3MBTL1ALDH1A1KDM4E
SCHEMBL2128330 0.69 ALDH1A1 (0.38) VEGFAEGLN1MAPTL3MBTL1ALDH1A1
SCHEMBL2124356 0.69 ALDH1A1 (0.38) MAPTL3MBTL1ALDH1A1KDM4E
SCHEMBL10104277 0.69 DPP4 (0.36) BRD4MAPTL3MBTL1ALDH1A1HTR6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2443111-A1 1,2,4-OXADIAZOL DERIVATIVES, THEIR PHARMACEUTICAL COMPOSITIONS AND THEIR USE AS SPHINGOSINE 1-PHOSPHATE 1 RECEPTOR AGONISTS Glaxo Group Limited (GB) 2012-04-25 — — EP disclosed
WO-2010145203-A1 1,2,4-OXADIAZOL DERIVATIVES, THEIR PHARMACEUTICAL COMPOSITIONS AND THEIR USE AS SPHINGOSINE 1-PHOSPHATE 1 RECEPTOR AGONISTS GLAXO GROUP LIMITED (GB) 2010-12-23 — — WO disclosed
Send feedback